Menu
Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

OPTIMIZING ANATOMICAL PATHOLOGY THROUGH IMPLEMENTATION OF SPECIMEN TRACKING

The Leica Biosystems Process and Solutions Optimization team has partnered with a major academic medical center to examine ways to further optimize their anatomic pathology lab and equipment. This laboratory was primarily interested in the impact that specimen tracking can have on increasing efficiency and patient safety.

The Leica Biosystems team presented a total solution that included BOND–III Fully Automated IHC and ISH Stainer, HistoCore PELORIS 3 Premium Tissue Processing System and CEREBRO Specimen Tracking System. The solution was designed to help them achieve their goals of patient safety and efficiency, while becoming a leader in anatomic pathology through technology and process improvement.

Figure 1 (above): Time Savings with CEREBRO

As part of comprehensive workflow assessment, the team gathered the data displayed in the table. By analyzing the data, we can demonstrate the following potential impacts:

  • Elimination of 6 paper logs
  • Elimination of 12 total steps in the process
  • A time savings of approximately 1040 hours/year
  • 28% increase in blocks per hour (61 without specimen tracking to 78.3 with specimen tracking).

By eliminating these tasks, this laboratory can continue to improve on their goal of becoming a technological leader in anatomic pathology, while reducing risk, improving quality, integrating solutions, and optimizing efficiency using the CEREBRO specimen tracking solution.

Instruments used in this case study

BOND-III Fully Automated IHC and ISH Stainer
HistoCore PELORIS 3 Premium Tissue Processing System
CEREBRO
Specimen Tracking System

This reference document is presented as a service to health care professionals by Leica Biosystems and has been compiled from available literature. Although every effort has been made to report faithfully the information, Leica Biosystems cannot be held responsible for the correctness. This document is not intended to be, and should not be construed as medical advice. For any use, the product information guides, inserts and operation manuals of the various drugs and devices should be consulted. Leica Biosystems and the editors disclaim any liability arising directly or indirectly from the use of drugs, devices, techniques or procedures described in this reference document.